Showing results (91-100 of 212) with videos related to
Sort By:
Pageof 22
Brain : a Journal of Neurology|December 2, 2008
Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsyMatteo Bologna, Rocco Agostino, Bruno Gregori, et al.Journal of Neurology|August 19, 2020
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson's diseaseMarina Picillo, Raffaele Palladino, Roberto Erro, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's diseaseFrancesca Romana Pezzella, Carlo Colosimo, Nicola Vanacore, et al.Neurotoxicity Research|October 16, 2015
Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysisMargherita Fabbri, Giorgio Leodori, Ricardo M Fernandes, et al.Parkinsonism & Related Disorders|June 24, 2014
Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control studyMaria Carmela Bloise, Isabella Berardelli, Valentina Roselli, et al.Cerebral Cortex (New York, N.Y. : 1991)|June 17, 2011
Abnormal cortical synaptic plasticity in primary motor area in progressive supranuclear palsyAntonella Conte, Daniele Belvisi, Matteo Bologna, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2004
Accuracy of clinical diagnosis of progressive supranuclear palsyYasushi Osaki, Yoav Ben-Shlomo, Andrew J Lees, et al.Expert Review of Neurotherapeutics|April 12, 2019
Disease-modifying therapies for tauopathies: agents in the pipelineFrancesco Panza, Bruno P Imbimbo, Madia Lozupone, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2015
Neuroimaging correlates of blinking abnormalities in patients with progressive supranuclear palsyMatteo Bologna, Maria Cristina Piattella, Neeraj Upadhyay, et al.BMC Research Notes|August 17, 2017
Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availabilityStefano Guadagni, Giancarlo Palumbo, Giammaria Fiorentini, et al.Pageof 22